טוען...
Long-term azithromycin use is not associated with QT prolongation in children with cystic fibrosis
Chronic Azithromycin is a common treatment for lung infection. Among adults at risk of cardiac events, AZM use has been associated with cardiovascular harm. We assessed cardiovascular safety of AZM among children with CF, as a secondary analysis of a placebo-controlled, clinical trial, in which stud...
שמור ב:
| הוצא לאור ב: | J Cyst Fibros |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8009808/ https://ncbi.nlm.nih.gov/pubmed/33246911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2020.11.005 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|